How should severely elevated blood pressure be managed before surgery?

Management of Severely Elevated Blood Pressure Before Surgery

For patients with severely elevated blood pressure (SBP ≥180 mm Hg or DBP ≥110 mm Hg) scheduled for elective major surgery, deferring surgery should be considered, especially in high-risk patients, to minimize perioperative complications. 1

Blood Pressure Thresholds for Proceeding vs. Deferring Surgery

The 2025 AHA/ACC guidelines provide clear thresholds based on severity:

• SBP <180 mm Hg and DBP <110 mm Hg: Proceed with surgery. There is little evidence that patients below these thresholds face significantly increased perioperative risk 1

• SBP ≥180 mm Hg or DBP ≥110 mm Hg: Consider deferring elective surgery (Class IIb recommendation, Level C-LD evidence) 1

The rationale is straightforward: severely elevated blood pressure increases risk of cardiovascular and cerebrovascular events, bleeding, and renal complications during the perioperative period 1. However, the evidence supporting specific thresholds is limited, which is why this remains a "may be considered" rather than definitive recommendation.

Medication Management Algorithm

Continue These Medications:

1. Beta-blockers: Must be continued throughout the perioperative period if patients are already taking them chronically (Class I recommendation) 1. Abrupt discontinuation causes rebound hypertension and is potentially harmful 1

2. Clonidine: Must be continued - abrupt discontinuation causes dangerous rebound hypertension with norepinephrine surge 1

3. Most other antihypertensives: Reasonable to continue throughout the perioperative period (Class IIa recommendation) 1

Consider Holding These Medications:

ACE inhibitors and ARBs: May be discontinued preoperatively to prevent intraoperative hypotension (Class IIb recommendation, Level B-R evidence) 1. This is controversial - the decision balances the risk of intraoperative hypotension against long-term cardiovascular protection.

Never Start These:

Beta-blockers on day of surgery: Do not initiate beta-blockers on the day of surgery in beta-blocker-naïve patients due to increased risk of postoperative mortality (Class III Harm recommendation) 1

Critical Pitfalls to Avoid

Common mistake: Aggressively lowering blood pressure in the days immediately before surgery. The guidelines explicitly state that without evidence for increased perioperative complications in patients with SBP/DBP <180/110 mm Hg, there is little reason to defer surgery 1. An elevated blood pressure on the day of surgery may represent "white-coat hypertension" if the patient had controlled blood pressure previously 1.

Key nuance: The relationship between systolic hypertension and surgical risk is less certain than for diastolic hypertension. Historical data showed increased cardiovascular and cerebrovascular complications with DBP >110 mm Hg, but patients with DBP <110 mm Hg do not appear at significantly increased risk 1.

Practical Decision-Making Framework

For patients presenting with SBP ≥180 or DBP ≥110:

1. Review baseline ambulatory blood pressure measurements - a single elevated reading may not reflect true hypertension 1

2. Assess cardiovascular risk factors and target organ damage (this determines risk more than blood pressure alone) 2

3. Evaluate surgery urgency and patient risk profile

4. If high-risk patient with truly uncontrolled hypertension: defer surgery, optimize blood pressure control over weeks to months, then reschedule 1

5. If lower-risk patient or urgent surgery: proceed with careful intraoperative blood pressure management using IV medications as needed 1, 2

Intraoperative Management

If surgery proceeds, maintain MAP ≥60-65 mm Hg or SBP ≥90 mm Hg to reduce risk of myocardial injury, acute kidney injury, and mortality 2. Manage with IV medications (clevidipine, nicardipine, esmolol, labetalol) until oral medications can be resumed 3, 4.

Important consideration: Assess contributing factors beyond blood pressure itself - volume status, pain control, oxygenation, and bladder distention all affect perioperative blood pressure and should be addressed 1.

The evidence base remains limited for specific management strategies, but the consensus is clear: severely elevated blood pressure (≥180/110 mm Hg) warrants consideration of deferral for elective surgery, while moderate elevations (<180/110 mm Hg) should not delay surgery in the absence of active end-organ damage.